1. Home
  2. MAX vs CBLL Comparison

MAX vs CBLL Comparison

Compare MAX & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediaAlpha Inc.

MAX

MediaAlpha Inc.

HOLD

Current Price

$10.37

Market Cap

722.8M

Sector

Industrials

ML Signal

HOLD

Logo CeriBell Inc.

CBLL

CeriBell Inc.

HOLD

Current Price

$17.92

Market Cap

750.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAX
CBLL
Founded
2014
2014
Country
United States
United States
Employees
N/A
280
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
722.8M
750.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MAX
CBLL
Price
$10.37
$17.92
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$14.58
$24.67
AVG Volume (30 Days)
1.3M
281.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
25.81
N/A
EPS
0.39
N/A
Revenue
$1,113,600,000.00
N/A
Revenue This Year
$10.18
$28.99
Revenue Next Year
$10.51
$28.30
P/E Ratio
$26.26
N/A
Revenue Growth
28.78
N/A
52 Week Low
$7.09
$10.01
52 Week High
$13.92
$24.33

Technical Indicators

Market Signals
Indicator
MAX
CBLL
Relative Strength Index (RSI) 62.27 33.98
Support Level $10.31 $16.62
Resistance Level $11.20 $18.29
Average True Range (ATR) 0.50 0.83
MACD 0.38 -0.21
Stochastic Oscillator 93.28 25.60

Price Performance

Historical Comparison
MAX
CBLL

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

About CBLL CeriBell Inc.

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Share on Social Networks: